A company with over 14 years of experience processing perinatal birth tissue products into therapeutic agents. Dr. Eliott Spencer, Ph.D., founder, owner and Chief Scientific Officer for Utah Cord Bank has decades of experience working with human tissues and cells. The founding philosophy was to bring innovation and value to stem cell-based medicine. Since 2004, the company has been an industry leader and innovator achieving a long list of industry firsts.

UCB has an impeccable safety record, with zero 483 FDA Corrective Action notices nor any serious adverse event reports and complies with FDA 21 CFR part 1271 section 361 regulations. The company prides itself on its state-of-the-art technology and its ability to provide products of the highest standards in the industry. Each product can be traced by its Tissue ID Number to the original donor if ever such need arises in the future. UCB continues to push delivery of stem cell medicine forward on every front.

Utah Cord Bank is a distinguished leader in the stem cell industry. Developing regenerative solutions that adhere to the highest quality standards, unique proprietary processes that maximize efficacy, and innovative use of cryopreservation resulting in a verified 85% cell viability post-thaw. The culmination of these strengths equals a concentration of therapeutic elements, providing an advantage to competitor products.